United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Nordic Capital proposes $846m acquisition of Advanz Pharma In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz… bypharmanewsdailyJanuary 27, 2021